Pharma Journalist -

Alora Pharmaceuticals, LLC, is pleased to announce that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of…
Read More...

JanOne Inc., a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced that it has completed the acquisition of Soin Therapeutics, LLC…
Read More...

Servier and Aqemia announce the extension of their new-molecule discovery collaboration on an undruggable therapeutic target in immuno-oncology. This extension follows Servier and…
Read More...

Selecta Biosciences, Inc. and Astellas Pharma Inc. announced an exclusive licensing and development agreement for IdeXork (Xork). Xork is being studied as a potential next generation…
Read More...

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments…
Read More...

ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced it has signed a multi-year research…
Read More...

Boehringer Ingelheim and 3T Biosciences, announced they have entered into a strategic collaboration and licensing agreement to discover and develop next-generation cancer therapies to…
Read More...

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that it has signed a multi-year research collaboration and option…
Read More...

Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), announced the signing of…
Read More...

AstraZeneca’s Biologics License Application (BLA) for nirsevimab has been accepted for review by the US Food and Drug Administration (FDA) for the prevention of respiratory syncytial…
Read More...